Page last updated: 2024-09-02

tryptoquivaline and Di Guglielmo Disease

tryptoquivaline has been researched along with Di Guglielmo Disease in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hassel, BA; Nakanishi, T; Ross, DD; Shiozawa, K	1
Hamada, A; Hirayama, C; Kawaguchi, T; Kuniyasu, A; Nakashima, R; Nakayama, H; Nanbu, T; Saito, H; Watanabe, H	1

Other Studies

2 other study(ies) available for tryptoquivaline and Di Guglielmo Disease

Article	Year
Complex interaction of BCRP/ABCG2 and imatinib in BCR-ABL-expressing cells: BCRP-mediated resistance to imatinib is attenuated by imatinib-induced reduction of BCRP expression. Blood, 2006, Jul-15, Volume: 108, Issue:2 Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Indoles; K562 Cells; Leukemia, Erythroblastic, Acute; Mitoxantrone; Neoplasm Proteins; Phosphatidylinositol 3-Kinases; Piperazines; Proto-Oncogene Proteins c-akt; Pyrimidines; RNA, Messenger; Signal Transduction; Transduction, Genetic	2006
Constitutive overexpression of P-glycoprotein, rather than breast cancer resistance protein or organic cation transporter 1, contributes to acquisition of imatinib-resistance in K562 cells. Pharmaceutical research, 2008, Volume: 25, Issue:4 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Blotting, Western; Cell Survival; Chromatography, High Pressure Liquid; Cyclosporine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Imatinib Mesylate; Indoles; K562 Cells; Leukemia, Erythroblastic, Acute; Neoplasm Proteins; Organic Cation Transporter 1; Piperazines; Polymerase Chain Reaction; Protein Kinase Inhibitors; Pyrimidines; Up-Regulation	2008

Article

Year

Complex interaction of BCRP/ABCG2 and imatinib in BCR-ABL-expressing cells: BCRP-mediated resistance to imatinib is attenuated by imatinib-induced reduction of BCRP expression.

Blood, 2006, Jul-15, Volume: 108, Issue:2

Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Indoles; K562 Cells; Leukemia, Erythroblastic, Acute; Mitoxantrone; Neoplasm Proteins; Phosphatidylinositol 3-Kinases; Piperazines; Proto-Oncogene Proteins c-akt; Pyrimidines; RNA, Messenger; Signal Transduction; Transduction, Genetic

2006

Constitutive overexpression of P-glycoprotein, rather than breast cancer resistance protein or organic cation transporter 1, contributes to acquisition of imatinib-resistance in K562 cells.

Pharmaceutical research, 2008, Volume: 25, Issue:4

Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Blotting, Western; Cell Survival; Chromatography, High Pressure Liquid; Cyclosporine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Imatinib Mesylate; Indoles; K562 Cells; Leukemia, Erythroblastic, Acute; Neoplasm Proteins; Organic Cation Transporter 1; Piperazines; Polymerase Chain Reaction; Protein Kinase Inhibitors; Pyrimidines; Up-Regulation

2008